http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04275265-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_324beb8b942a3a6ed1f1f576bcd76c45
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C245-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04
filingDate 1991-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5456ab0ca09f11d6c05d1f76be10ec0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_691d17003b2213d06f7bf7a1d19caf4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1cff2ad813314a10823a3b17c4c9990
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d9ef87f39cffbd1b6e5eafb88354fe0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fe4a0ff34a2019d6e709af64f9abe4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eda5312f70fa8671115795ac543cbc6d
publicationDate 1992-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H04275265-A
titleOfInvention Alpha-amino acid derivative
abstract PURPOSE: To obtain a new compound, an antagonist of inhibitory glycine receptor, useful as a treating agent for non-keto-cis type, an agent for central excitatory state, a medicine similar to strychnine and a physical and chemical reagent. n CONSTITUTION: A compound shown by formula I (X is sulfo, 1H-tetrazol-5-yl, etc.; R 1 to R 3 are H, 1-6C alkyl, aralkyl or aryl; R 4 to R 7 are H, halogen, 1-6C lower or 1-6C lower alkoxy; m and n are 1-8), such as 2-amino-3-[2-(2- phosphonomethyl)phenyl]propionic acid. The compound shown by formula I is obtained by hydrolyzing and decarboxylating a compound shown by formula II (Y 1 is 1H-tetrazol-5-yl, etc.; Z is amino-protecting group) under an acidic condition with hydrochloric acid, etc., in a solvent such as acetic acid at 50-120°C for 12-120 hours. n COPYRIGHT: (C)1992,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6855843-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7476758-B2
priorityDate 1991-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226471508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413807576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233869151
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1040935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1032
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1040935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID383689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811

Total number of triples: 42.